Angiomax in Patients With HIT/HITTS Type II Undergoing CPB
NCT00079508
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
125
Enrollment
INDUSTRY
Sponsor class
Conditions
Cardiovascular Disease
Coronary Artery Bypass Surgery
Interventions
DRUG:
Angiomax (bivalirudin)
Sponsor
The Medicines Company